Xenothera Announces Publication in European Journal of Clinical Investigation on Immunological Mechanisms Underlining Use of LIS1
Kidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...
More
XENOTHERA to raise Series A
XENOTHERA has started to gather investors for a Series A round of...
More
XENOTHERA sponsors the realization of a fresco for the hospital by transplanted patients
Nantes, november 2017 The fresco, more than 8 meters long, has been...
More
XENOTHERA nominated for the Ernst&Young Entrepreneur Award
Nantes, September 2017 We have been selected for the 2017 entrepreneur awards...
More
Distinction: Jean-Paul SOULILLOU awarded for its international exceptional career and contribution in transplantation
August 25th, 2016 XENOTHERA, a young start-up from Nantes, is honored to...
More
Press Release: Start-up XENOTHERA closes a new capital increase above 2 million euros
June 10th, 2016 XENOTHERA, a young biotech who develops an innovative immunosuppressant,...
More
XENOTHERA moved to the Medicine Faculty of Nantes
September 1st, 2015 The Medicine Faculty of Nantes is welcoming the start-up...
More
XENOTHERA at Melbourne 2015 IXA
July 24th, 2015 Several partners of XENOTHERA will be present at the...
More
XENOTHERA at Biopharm America™ 2015
July 23th, 2015 XENOTHERA will participate in the Biopharm America that will...
More